Australia markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1200-0.0100 (-0.88%)
At close: 03:58PM EDT
1.1300 +0.01 (+0.89%)
After hours: 07:30PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1300
Open1.1500
Bid0.0000 x 800
Ask0.0000 x 1800
Day's range1.1041 - 1.2525
52-week range1.1040 - 12.4800
Volume4,175
Avg. volume34,847
Market cap4.06M
Beta (5Y monthly)1.49
PE ratio (TTM)N/A
EPS (TTM)-2.5900
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

    Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq L

  • GlobeNewswire

    Universe Pharmaceuticals INC Announces Share Consolidation

    Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Conso

  • GlobeNewswire

    Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

    Ji’an, Jiangxi, China, March 07, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 2, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Lis